LON:C4XD C4X Discovery (C4XD) Share Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range 12▼ 1252-Week Range N/AVolume3.77 million shsAverage Volume1.18 million shsMarket Capitalization£30.27 millionP/E Ratio300.00Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesStock AnalysisAnalyst ForecastsChartHeadlines Get C4X Discovery alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About C4X Discovery Stock (LON:C4XD)C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.Read More Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. C4XD Stock News HeadlinesJuly 22, 2024 | finanznachrichten.deC4X Discovery Holdings PLC: C4X Discovery Holdings Limited announces progress on immuno-inflammation programmes and appointment of new Board membersJuly 22, 2024 | finanznachrichten.deC4X Discovery Holdings PLC: C4X Discovery announces progress on immuno-inflammation programmes and appointment of new Board membersJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 22, 2024 | finance.yahoo.comC4X Discovery Holdings Limited announces progress on immuno-inflammation programmes and appointment of new Board membersJuly 21, 2024 | americanbankingnews.comC4X Discovery (LON:C4XD) Stock Passes Above 50 Day Moving Average of $12.00July 19, 2024 | ft.comUK biotech, what’s in it for retail investors?March 27, 2024 | marketwatch.comC4X Discovery to Delist From AIM Due to Downturn in Financial MarketsMarch 27, 2024 | msn.comAnother listed company plans to quit London’s AIM market – this is whyJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.February 26, 2024 | msn.comSMALL CAP IDEA: AIM healthcare stock C4X struggles for market reward despite business progressJanuary 26, 2024 | finance.yahoo.comHere's Why We're Watching C4X Discovery Holdings' (LON:C4XD) Cash Burn SituationJanuary 23, 2024 | morningstar.comC4X Discovery Holdings PLC C4XDJanuary 3, 2024 | msn.comUK grocery price inflation slows to 6.7% as retailers enjoy busiest Christmas since 2019, data shows – business liveJanuary 3, 2024 | marketwatch.comC4X Discovery Shares Rise on AstraZeneca Milestone PaymentJanuary 3, 2024 | thetimes.co.ukAstraZeneca payout pushes C4X share price up 50%December 20, 2023 | lse.co.ukPosting of 2023 Annual Report and Notice of AGMDecember 16, 2023 | finance.yahoo.comC4X Discovery Holdings plc (LON:C4XD) Is About To Turn The CornerOctober 30, 2023 | news.yahoo.comCustoms and Border Protection makes bizarre discovery at O'HareSee More Headlines Receive C4XD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for C4X Discovery and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/29/2020Today7/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:C4XD CUSIPN/A CIKN/A Webwww.c4xdiscovery.com Phone+44-161-2355085FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.04 Trailing P/E Ratio300.00 Forward P/E RatioN/A P/E GrowthN/ANet Income£10.57 million Net Margins42.81% Pretax MarginN/A Return on Equity55.38% Return on Assets28.04% Debt Debt-to-Equity Ratio1.05 Current Ratio15.31 Quick Ratio9.82 Sales & Book Value Annual Sales£24.68 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow4.00 Book ValueGBX 10 per share Price / BookN/AMiscellaneous Outstanding Shares252,230,000Free FloatN/AMarket Cap£30.27 million OptionableNot Optionable Beta0.23 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Clive James Dix B.Sc. (Age 70)Ph.D., Interim Executive Chairman & CEO Comp: $211kMr. Bradley Richard Hoy (Age 62)CFO, Secretary & Executive Director Comp: $242kMs. Bhavna Hunjan (Age 39)Chief Business Officer & Executive Director Comp: $218kMs. Emma Blaney Ph.D.Chief Operating OfficerDr. Nick Ray Ph.D.Chief Scientific OfficerDr. Clare Murray Ph.D.Senior Vice President of Drug DiscoveryMore ExecutivesKey CompetitorsTiziana Life SciencesLON:TILSVerseonLON:VSNFutura MedicalLON:FUMFaron Pharmaceuticals OyLON:FARNMereo BioPharma Group plc (MPH.L)LON:MPHView All CompetitorsInsidersClive DixBought 485,320 shares on 4/8/2024Total: £4.85 M ($10.00/share) C4XD Stock Analysis - Frequently Asked Questions How were C4X Discovery's earnings last quarter? C4X Discovery Holdings plc (LON:C4XD) announced its quarterly earnings results on Wednesday, April, 29th. The company reported ($5.02) EPS for the quarter, topping analysts' consensus estimates of ($5.50) by $0.48. C4X Discovery had a net margin of 42.81% and a trailing twelve-month return on equity of 55.38%. How do I buy shares of C4X Discovery? Shares of C4XD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of C4X Discovery own? Based on aggregate information from My MarketBeat watchlists, some other companies that C4X Discovery investors own include Rio Tinto Group (RIO), Ryder System (R), Pearson (PSON), Moss Bros Group (MOSB), Inland Homes (INL) and Fundsmith Emerging Equities Trust (FEET). This page (LON:C4XD) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4X Discovery Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share C4X Discovery With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.